Low molecular weight heparin (LMWH) treatment in cancer patients with low risk venous thromboembolism - results of Turkish Observational Study (TREBECA)


Ozkan M., Cicin I., Ozaslan E., Benekli M., Oksuzoglu B., Kocer M., ...More

European Cancer Congress, Vienna, Austria, 01 January 2015, vol.51 identifier